253 related articles for article (PubMed ID: 26005937)
1. [Strongyloidiasis in nephrologic patients].
Gravellone L; Battaglia C; Caligara F; D'Amato I; Gandini E; Lucatello A; Rizzo MA; Torpia R; Brigante G; Castiglioni A
G Ital Nefrol; 2015; 32(2):. PubMed ID: 26005937
[TBL] [Abstract][Full Text] [Related]
2. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
Segarra-Newnham M
Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
[TBL] [Abstract][Full Text] [Related]
3. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated strongyloidiasis].
Nozais JP; Thellier M; Datry A; Danis M
Presse Med; 2001 Apr; 30(16):813-8. PubMed ID: 11388155
[TBL] [Abstract][Full Text] [Related]
5. Management of severe strongyloidiasis attended at reference centers in Spain.
Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F;
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356
[TBL] [Abstract][Full Text] [Related]
6. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
[TBL] [Abstract][Full Text] [Related]
7. [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other].
Saïd S; Nevez G; Morinière P; Fournier A; Raccurt CP
Nephrologie; 1999; 20(6):343-6. PubMed ID: 10592937
[TBL] [Abstract][Full Text] [Related]
8. Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment.
Mattioni S; Valin N; Cracco C; Thellier M; Danis M; Caumes E
Ann Trop Med Parasitol; 2008 Dec; 102(8):693-8. PubMed ID: 19000386
[TBL] [Abstract][Full Text] [Related]
9. Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics.
Agrawal V; Agarwal T; Ghoshal UC
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):242-6. PubMed ID: 18804829
[TBL] [Abstract][Full Text] [Related]
10. Management of Strongyloides stercoralis: a puzzling parasite.
Luvira V; Watthanakulpanich D; Pittisuttithum P
Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
[TBL] [Abstract][Full Text] [Related]
11. Case report: strongyloidiasis refractory to treatment with ivermectin.
Ashraf M; Gue CL; Baddour LM
Am J Med Sci; 1996 Apr; 311(4):178-9. PubMed ID: 8602647
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies in controlling strongyloidiasis.
Satoh M; Kokaze A
Expert Opin Pharmacother; 2004 Nov; 5(11):2293-301. PubMed ID: 15500376
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
14. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
Hennessey DC; Ballesteros ÓA; Merchán DJ; Guevara FO; Severiche DF
Biomedica; 2020 Jun; 40(2):228-232. PubMed ID: 32673452
[TBL] [Abstract][Full Text] [Related]
16. Strongyloides hyperinfection: a treatment dilemma.
Miller MA; Church LW; Salgado CD
Am J Med Sci; 2008 Oct; 336(4):358-61. PubMed ID: 18854683
[TBL] [Abstract][Full Text] [Related]
17. Strongyloides hyperinfection syndrome complications: a case report and review of the literature.
Najmuddin A; Hadique S; Parker J
W V Med J; 2012; 108(1):32-8. PubMed ID: 25134190
[TBL] [Abstract][Full Text] [Related]
18. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
19. Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia.
Gulbas Z; Kebapci M; Pasaoglu O; Vardareli E
South Med J; 2004 Sep; 97(9):907-10. PubMed ID: 15455986
[TBL] [Abstract][Full Text] [Related]
20. [A case of strongyloidiasis hyperinfection during oral corticosteroid therapy associated with a nephrotic patient infected with HTLV-1].
Mitsunaga M; Miyauchi N; Akiyama Y; Saima S
Nihon Ronen Igakkai Zasshi; 2003 Jul; 40(4):397-401. PubMed ID: 12934572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
